RAC supplies reference standards for 11 Orlistat impurities, including Orlistat Impurity 1 and Orlistat Impurity 13. Every lot is released with a certificate stating HPLC purity, MS and 1H NMR data, produced under ISO 17034:2016 (ANAB, AR-2832). All items are scheduled on synthesis, typically 3-4 weeks. Pharmacopoeial items follow the monograph numbering (EP, USP, BP); non-pharmacopoeial items are characterised against the drawn structure, and can be re-qualified against your own method on request.
| Padrão | CAS | Status | |
|---|---|---|---|
| Orlistat Impurity 1 | 3084279-49-9 | EM SÍNTESE | |
| Orlistat Impurity 13 | 130676-66-3 | EM SÍNTESE | |
| Orlistat Impurity 14 | 130793-26-9 | EM SÍNTESE | |
| Orlistat Impurity 15 | 130676-65-2 | EM SÍNTESE | |
| Orlistat Impurity 2 | 104872-28-8 | EM SÍNTESE | |
| Orlistat Impurity 26 | 68711-33-1 | EM SÍNTESE | |
| Orlistat Impurity 27 | 155548-91-7 | EM SÍNTESE | |
| Orlistat Impurity 28 | 160549-09-7 | EM SÍNTESE | |
| Orlistat Impurity 34 | 96829-59-3 | EM SÍNTESE | |
| Orlistat impurity 41 | 68659-61-0 | EM SÍNTESE | |
| Orlistat Impurity 7 | 6113-61-7 | EM SÍNTESE |
Prices are quoted per enquiry — pack size, documentation and shipping are confirmed together.
Metabolites, NDSRI nitrosamines and degradation products of Orlistat that no catalogue lists — typically 3–4 weeks from 10 mg to gram scale, released with the same certificate.
—